- New gene therapy for Usher F1.
- New research on diabetes related retinal diseases.
- Surgery helping with corneal blindness.
- And 3 other stories about the science and medicine related to blindness from the entire world.
Editorial By Chris Hofstader
This is the second slow week in a row for news about the science of blindness and blind people. This edition has about six stories, they're all pretty interesting but the mainstream media did little to report on the science of blindness this week.
World Blind herald does not write the stories to which we link in Science Briefs, we gather them, curate them and bring them to our readers. We are not scientists ourselves and cannot guarantee the validity of the stories in this digest. We do, however, want to be very clear that you should not attempt any of the medical interventions mentioned in Science Briefs without first consulting a professional ophthalmologist and discussing it with them. Do not take medical advice from this or any other web site or podcast without first consulting a professional.
Blind Girl Designs
Blind Girl Designs, fun and unique apparel for you!
We have creative, delightful, white cane inspired prints on T-shirts, sweatshirts and hoodies.
We also carry dresses and cardigans size Small-XXL.
Call us at 862-448-1011, for an audio description or to place an order. Visit our website.
Science and Medicine
New mini gene therapy could successfully restore hearing and sight to those who suffer from Usher 1F. This story comes to us from: RegMedNet.
Diseases due to the present-day lifestyle are resulting in complete blindness, they said. This story comes to us from: Telangana Today.
A 64-year-old female, Maria Fernandes, was blind in one eye due to a failed corneal graft, having undergone the same at Chennai, Tamil Nadu. This story comes to us from: Goa Chronicle.
Know More: A leading cause of blindness worldwide, trachoma is an infectious disease of the eye caused by the bacterium Chlamydia trachomatis. This story comes to us from: TheHealthSite.com.
Augusta University researcher secures prestigious grant for research to prevent blindness in premature infants
an assistant research scientist who studies retinal neurovascular biology in the Vascular Biology Center of the Medical College of Georgia at Augusta University, has received a prestigious grant from the Knights Templar Eye Foundation for his research on blindness in premature infants. This story comes to us from: Augusta – Augusta University.
The research conducted at the Wayne State University School of Medicine implies that VCAM1 antagonism could be a promising therapeutic strategy for proliferative retinal disorders. This story comes to us from: Modern Retina.
Timely medical interventions in the form of screening, diagnosis, … organised to detect eye conditions at early stages and prevent blindness. This story comes to us from: Pharmabiz.com.